Identification of potential therapeutic targets in prostate cancer through a cross‐species approach-Reference-Cited by-同舟云学术

Identification of potential therapeutic targets in prostate cancer through a cross‐species approach

Published:2018-02-05 Issue:3 Volume:10 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Jurmeister Sarah¹^ORCID,Ramos‐Montoya Antonio¹,Sandi Chiranjeevi¹,Pértega‐Gomes Nelma²,Wadhwa Karan¹,Lamb Alastair D¹³⁴,Dunning Mark J⁵^ORCID,Attig Jan⁶⁷^ORCID,Carroll Jason S⁸,Fryer Lee GD¹,Felisbino Sérgio L⁹,Neal David E¹³⁴

Affiliation:

1. Uro‐oncology Research Group CRUK Cambridge Institute Cambridge UK

2. Department of Medical Oncology Dana‐Farber Cancer Institute Harvard Medical School Boston MA USA

3. Department of Urology University of Cambridge Cambridge UK

4. Department of Oncology Addenbrooke's Hospital Cambridge UK

5. Bioinformatics Core Facility CRUK Cambridge Institute Cambridge UK

6. Department of Molecular Neuroscience UCL Institute of Neurology London UK

7. MRC‐Laboratory of Molecular Biology Cambridge UK

8. Cancer Research UK Cambridge Institute University of Cambridge Cambridge UK

9. Department of Morphology Institute of Biosciences of Botucatu Sao Paulo State University (UNESP) Sao Paulo Brazil

Funder

Cancer Research UK

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201708274

Reference72 articles.

1. AbramsonRG(2014)Overview of targeted therapies for cancer. My Cancer Genomehttp://www.mycancergenome.org/content/other/molecular-medicine/overview-of-targeted-therapies-for-cancer/

2. Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia

3. The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor

4. Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

5. Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-fat diet impact on prostate gland from adiponectin knockout mice: Morphometric, metabolic and inflammatory cytokines analyses;Life Sciences;2024-11

2. Targeting MELK in tumor cells and tumor microenvironment: from function and mechanism to therapeutic application;Clinical and Translational Oncology;2024-08-26

3. Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1/JAK2/STAT3 pathway in gastric cancer;Cancer Cell International;2024-08-12

4. Deregulation of ABCG1 early in life contributes to prostate carcinogenesis in maternally malnourished offspring rats;Molecular and Cellular Endocrinology;2024-01

5. Cytotoxic effect of Ziziphus Spina-Christi extract alone and in combination with doxorubicin on breast cancer cells;The Ukrainian Biochemical Journal;2023-12-14